24 July, 2023Crescendo Biologics secures $32M and announces expansion of CB307 Phase 1b trial in PSMA+ solid tumors
12 July, 2023Tenpoint Therapeutics launches with $70 million Series A financing to reverse vision loss through engineered cell-based therapeutics and in vivo reprogramming